Results 181 to 190 of about 12,325 (203)

Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2021
Mali Okada, Robert P Finger, Bora Eldem   +2 more
exaly  

Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data

Ophthalmology, 2020
David Sarraf, K Bailey Freund, Srinivas R Sadda   +2 more
exaly  

Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches

International Journal of Molecular Sciences, 2020
Federico Ricci, Francesco Bandello, Pierluigi Navarra   +2 more
exaly  

Neutrophil-To-Lymphocyte Ratio as a Potential Biomarker of Neovascular Glaucoma

Ocular Immunology and Inflammation, 2021
Aiping Zhang, Jianping Han, Yingbo Ma
exaly  

Neovascular Glaucoma

2016
Julia Lüke, Matthias Lüke, Salvatore Grisanti   +2 more
openaire   +2 more sources

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2022
Peter A Campochiaro, Daniel Miller, Dante J Pieramici   +2 more
exaly  

Neovascular Glaucoma

2008
James C. Tsai, Martin Wand
openaire   +1 more source

<p>Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration</p>

Clinical Ophthalmology, 2019
K Bailey Freund
exaly  

Recent Advances in the Management of Neovascular Glaucoma

Seminars in Ophthalmology, 2013
Jeffrey R Soohoo, Leonard K Seibold, Malik Y Kahook   +2 more
exaly  

Neovascular Glaucoma

2022
openaire   +1 more source